Physicians would have to register with the Drug Enforcement Administration (DEA) for telehealth prescribing of certain controlled substances under a proposed rule issued Wednesday by the agency.

A federal appellate court has upheld the Drug Enforcement Administration’s denial of a Seattle doctor’s request to use ...

One such exception is for providers who hold a “special registration,” the details of which were left within the DEA’s purview. This is the first time the DEA has proposed a special ...

The Drug Enforcement Administration ("DEA") announced three new regulations related to the prescription of controlled substances resulting from ...

On Wednesday, the DEA released a proposed rule that would set up a special registration process for remote prescribing of Schedule II-V controlled substances such as Xanax, Vicodin and Adderall.

The move finally fulfills a mandate that DEA had largely ignored since Congress first issued it in 2008. But the new special registration system is merely a proposal, meaning the incoming Trump ad ...

The DEA recently released three rules regarding the remote prescribing of controlled substances. However, many telehealth ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins Some states have laws and ethical rules regarding solicitation and ...

“The proposed registration requirements for telemedicine-based prescribing and dispensing create a new business activity within DEA’s overarching registration framework, distinguishing it from ...

May threaten arrest, prosecution, imprisonment, and, in the case of medical practitioners, revocation of their DEA registration. –May involve the target practitioner in a realistic arrest/search ...